Literature DB >> 20603854

Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision.

O C Shihab1, P Quirke, R J Heald, B J Moran, G Brown.   

Abstract

BACKGROUND: In rectal cancer the management of suspicious magnetic resonance imaging (MRI)-detected lymph nodes lying close to the mesorectal fascia poses an ongoing dilemma. Key decisions in treatment planning are commonly based on the prediction of margin status. However, it is unclear whether a lymph node that appears to contain tumour close to the mesorectal fascia will result in a positive margin.
METHODS: Some 396 patients with rectal cancer were included. MRI assessment of mesorectal nodes, the pathologically involved circumferential resection margin (CRM) rate and causes of margin involvement were analysed to establish the clinical significance of MRI-detected suspicious lymph nodes at the resection margin.
RESULTS: Fifty (12.6 per cent) of 396 patients had a positive CRM on histopathological analysis, five (10 per cent) solely due to an involved lymph node. Four of the five malignant nodes were not predicted on MRI. Thirty-one of the 396 MRI studies had suspicious nodes 1 mm or less from the CRM. None of these patients had a positive CRM owing to nodal involvement.
CONCLUSION: Involvement of the CRM by lymph node metastases alone is uncommon. Copyright 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20603854     DOI: 10.1002/bjs.7116

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  The influence of metastatic lymph nodes at the circumferential resection margin of rectal cancer-Do these lymph nodes require any special attention?

Authors:  G P São Julião; R O Perez
Journal:  Tech Coloproctol       Date:  2019-03-18       Impact factor: 3.781

2.  Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies.

Authors:  S Balyasnikova; N Haboubi; B Moran; G Brown
Journal:  Tech Coloproctol       Date:  2016-12-07       Impact factor: 3.781

3.  Management of distal rectal cancer: results from a national survey.

Authors:  G Melotti; E De Antoni; A Habr-Gama; A Minicozzi
Journal:  Updates Surg       Date:  2013-01-19

Review 4.  Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI.

Authors:  Marc J Gollub; Chandana Lall; Neeraj Lalwani; Michael H Rosenthal
Journal:  Abdom Radiol (NY)       Date:  2019-11

Review 5.  MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response.

Authors:  David D B Bates; Maria El Homsi; Kevin J Chang; Neeraj Lalwani; Natally Horvat; Shannon P Sheedy
Journal:  Clin Colorectal Cancer       Date:  2021-11-14       Impact factor: 4.481

6.  Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.

Authors:  Alfonso Reginelli; Vincenza Granata; Roberta Fusco; Francesco Granata; Daniela Rega; Luca Roberto; Gianluca Pellino; Antonio Rotondo; Francesco Selvaggi; Francesco Izzo; Antonella Petrillo; Roberto Grassi
Journal:  Oncotarget       Date:  2017-04-04

Review 7.  Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology.

Authors: 
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

Review 8.  Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.

Authors:  Adriana Dieguez
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

Review 9.  Imaging Advances in Colorectal Cancer.

Authors:  Svetlana Balyasnikova; Gina Brown
Journal:  Curr Colorectal Cancer Rep       Date:  2016-04-27

Review 10.  Radiological assessment of anal cancer: an overview and update.

Authors:  Vincenza Granata; Roberta Fusco; Alfonso Reginelli; Luca Roberto; Francesco Granata; Daniela Rega; Antonio Rotondo; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2016-10-12       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.